Reference
Malmestrom C, et al. First reported case of diabetes mellitus type 1 as a possible secondary autoimmune disease following alemtuzumab treatment in MS. Journal of Neurology 261: 2016-2018, No. 10, Oct 2014. Available from: URL: http://doi.org/10.1007/s00415-014-7448-y - Sweden
Rights and permissions
About this article
Cite this article
Alemtuzumab. Reactions Weekly 1559, 18 (2015). https://doi.org/10.1007/s40278-015-3207-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-015-3207-9